Ticker > Company >

Unjha Formulations share price

Unjha Formulations Ltd.

BSE: 531762 SECTOR: Pharmaceuticals & Drugs  10.84 K   25   1

24.92
-0.96 (-3.71%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 25.8

Today's Low

₹ 24.62

52 Week High

₹ 39

52 Week Low

₹ 19.99

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

11.17 Cr.

Enterprise Value

10.52 Cr.

No. of Shares

0.45 Cr.

P/E

113.95

P/B

3.17

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  7.87

CASH

0.64 Cr.

DEBT

0 Cr.

Promoter Holding

36.92 %

EPS (TTM)

₹  0.22

Sales Growth

-25.05%

ROE

13.88 %

ROCE

18.11%

Profit Growth

46.64 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-25.05%
3 Year-0.72%
5 Year5.51%

Profit Growth

1 Year46.64%
3 Year17.3%
5 Year5.73%

ROE%

1 Year13.88%
3 Year12.27%
5 Year10.94%

ROCE %

1 Year18.11%
3 Year18.13%
5 Year20.47%

Debt/Equity

0

Price to Cash Flow

-248.67

Interest Cover Ratio

65.6296

CFO/PAT (5 Yr. Avg.)

0.223537502572808

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 36.92 0.00
Mar 2025 36.92 0.00
Dec 2024 36.92 0.00
Sep 2024 36.92 0.00
Jun 2024 36.92 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 18.7952 days.
  • Company has a healthy liquidity position with current ratio of 2.3739.

 Limitations

  • The company has shown a poor revenue growth of -0.715588100246967% for the Past 3 years.
  • Company has negative cash flow from operations of -0.0449.
  • The company has a low EBITDA margin of 3.19393161161962% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 32.2611.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 3.95 3.81 3.76 2.44 3.63
Total Expenditure 3.23 3.89 3.52 2.7 3.21
Operating Profit 0.72 -0.09 0.24 -0.26 0.42
Other Income 0 0 0.01 0 0
Interest 0 0 0 0 0
Depreciation 0.02 0.02 0.02 0.03 0.03
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.7 -0.11 0.23 -0.29 0.39
Tax 0 0 0 0.12 0
Profit After Tax 0.7 -0.11 0.23 -0.41 0.39
Adjusted EPS (Rs) 1.56 -0.24 0.5 -0.91 0.87

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 9.96 14.16 13.15 18.5 13.86
Total Expenditure 9.59 13.84 12.72 17.92 13.36
Operating Profit 0.36 0.32 0.43 0.58 0.5
Other Income 0.22 0.19 0.03 0.01 0.13
Interest 0.17 0.13 0.06 0.05 0.01
Depreciation 0.08 0.08 0.08 0.08 0.1
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.33 0.3 0.33 0.45 0.52
Tax 0.23 0.05 0.05 0.17 0.12
Net Profit 0.1 0.25 0.28 0.28 0.41
Adjusted EPS (Rs.) 0.23 0.56 0.63 0.62 0.91

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.48 4.48 4.48 4.48 4.48
Total Reserves -2.56 -2.31 -2.03 -1.75 -1.34
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 0.01 0
Current liabilities 1.61 1.28 0.96 2.2 1.41
Total Liabilities 3.53 3.45 3.41 4.93 4.56
Assets
Net Block 1.12 1.07 1.1 1.12 1.2
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 2.4 2.38 2.31 3.81 3.35
Total Assets 3.53 3.45 3.41 4.93 4.56
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.1 0.25 0.33 0.45 0.52
Adjustment 0.25 0.21 0.13 0.13 0.07
Changes in Assets & Liabilities -0.89 -0.05 -0.67 0.49 -0.5
Tax Paid 0 0 -0.05 -0.05 -0.14
Operating Cash Flow -0.7 0.28 -0.26 1.03 -0.04
Investing Cash Flow -0.06 -0.02 -0.1 -0.11 -0.18
Financing Cash Flow 0 0 -0.06 -0.05 -0.01
Net Cash Flow -0.77 0.26 -0.42 0.86 -0.23

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 36.92 36.92 36.92 36.92 36.92
jashodaben shambhubhai pa... 16.51 16.51 16.51 16.51 16.51
krutiben mayankkumar pate... 14.89 14.89 14.89 14.89 14.89
neenaben urveshkumar pate... 1.90 1.90 1.90 1.90 1.90
urveshkumar shambhubhai p... 3.62 - 3.62 3.62 3.62
urveshkumar shambhbhai pa... - 3.62 - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 63.08 63.08 63.08 63.08 63.08
deep mayankbhai patel 1.29 - - 1.29 1.29
esha mayank patel 1.60 1.60 - 1.60 1.60
jatinkumar babulal patel 1.06 1.06 - 1.06 1.06
manish patel 1.32 1.32 1.35 1.35 1.39
narveer yadav 1.17 1.17 1.17 1.17 1.17
deep mayank patel - 1.29 1.29 - -
esha patel - - 1.60 - -
jatin b patel - - 1.06 - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Unjha Formulations - Quaterly Results 6 Aug, 2:13 PM Unjha Formulations - Quaterly Results 6 Aug, 2:13 PM Unjha Formulations - Quaterly Results 6 Aug, 2:13 PM Unjha Formulations - Quaterly Results 16 May, 3:07 PM Unjha Formulations - Quaterly Results 16 May, 3:07 PM Unjha Formulations - Quaterly Results 16 May, 3:07 PM Unjha Formulations - Quaterly Results 4 Feb, 2:01 PM Unjha Formulations - Quaterly Results 4 Feb, 2:01 PM Unjha Formulations - Quaterly Results 4 Feb, 2:01 PM Unjha Formulations - Quaterly Results 8 Nov, 1:48 PM Unjha Formulations - Quaterly Results 8 Nov, 1:48 PM Unjha Formulations - Quaterly Results 8 Nov, 1:48 PM Unjha Formulations informs about compliance certificate 11 Oct, 5:34 PM Unjha Formulations - Quaterly Results 1 Aug, 2:24 PM Unjha Formulations - Quaterly Results 1 Aug, 2:24 PM Unjha Formulations - Quaterly Results 1 Aug, 2:24 PM Unjha Formulations - Quaterly Results 17 May, 3:18 PM Unjha Formulations - Quaterly Results 17 May, 3:18 PM Unjha Formulations - Quaterly Results 17 May, 3:18 PM Unjha Formulations informs about board meeting 8 May, 5:20 PM Unjha Formulations - Quaterly Results 29 Jan, 2:06 PM Unjha Formulations - Quaterly Results 29 Jan, 2:06 PM Unjha Formulations - Quaterly Results 29 Jan, 2:06 PM Unjha Formulations - Quaterly Results 4 Aug, 2:31 PM Unjha Formulations - Quaterly Results 4 Aug, 2:31 PM Unjha Formulations - Quaterly Results 4 Aug, 2:31 PM Unjha Formulations - Quaterly Results 10 May, 3:01 PM Unjha Formulations - Quaterly Results 10 May, 3:01 PM Unjha Formulations - Quaterly Results 10 May, 3:01 PM Unjha Formulations informs about change in promoters shareholding 14 Mar, 1:00 PM Unjha Formulations - Quaterly Results 10 Feb, 1:20 PM Unjha Formulations - Quaterly Results 10 Feb, 1:20 PM Unjha Formulations - Quaterly Results 10 Feb, 1:20 PM Unjha Formulations - Quaterly Results 10 Nov, 1:10 PM Unjha Formulations - Quaterly Results 10 Nov, 1:10 PM Unjha Formulations - Quaterly Results 4 Aug, 1:29 PM Unjha Formulations - Quaterly Results 4 Aug, 1:29 PM Unjha Formulations - Quaterly Results 4 Aug, 1:29 PM Unjha Formulations informs about book closure 13 Jul, 4:08 PM Unjha Formulations - Quaterly Results 2 May, 2:40 PM Unjha Formulations - Quaterly Results 2 May, 2:40 PM Unjha Formulations - Quaterly Results 2 May, 2:40 PM Unjha Formulations informs about board meeting intimation 18 Apr, 4:47 PM Unjha Formulations - Quaterly Results 4 Feb, 1:24 PM Unjha Formulations - Quaterly Results 4 Feb, 1:24 PM Unjha Formulations - Quaterly Results 4 Feb, 1:24 PM Unjha Formulations informs about filing of distribution schedule 28 Aug, 2:35 PM Unjha Formulations informs about outcome of board meeting 23 Mar, 3:23 PM Unjha Formulations informs about board meeting 17 Mar, 11:09 AM Unjha Formulations informs about newspaper publication 10 Nov, 11:09 AM

Unjha Formulations Stock Price Analysis and Quick Research Report. Is Unjha Formulations an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Unjha Formulations. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Unjha Formulations has a PE ratio of 113.946044810242 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Unjha Formulations has ROA of 8.5885% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Unjha Formulations has a Current ratio of 2.3739.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Unjha Formulations has a ROE of 13.8844%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Unjha Formulations has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Unjha Formulations has reported revenue growth of -25.0535% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Unjha Formulations for the current financial year is 3.62643466718606%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Unjha Formulations is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Unjha Formulations is Rs 0.2187. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Unjha Formulations in Ticker for free. Also, one can get the intrinsic value of Unjha Formulations by using Valuation Calculators, which are available with a Finology ONE subscription. 

Unjha Formulations FAQs

Q1. What is Unjha Formulations share price today?
Ans: The current share price of Unjha Formulations is Rs 24.92.

Q2. What is the market capitalisation of Unjha Formulations?
Ans: Unjha Formulations has a market capitalisation of Rs 11.165406 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Unjha Formulations?
Ans: The PE ratio of Unjha Formulations is 113.946044810242 and the P/B ratio of Unjha Formulations is 3.16504731059884, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Unjha Formulations share?
Ans: The 52-week high share price of Unjha Formulations is Rs 39, and the 52-week low share price of Unjha Formulations is Rs 19.99.

Q5. Does Unjha Formulations pay dividends?
Ans: Currently, Unjha Formulations does not pay dividends. Dividend yield of Unjha Formulations is around 0%.

Q6. What are the face value and book value of Unjha Formulations shares?
Ans: The face value of Unjha Formulations shares is Rs 10, while the book value per share of Unjha Formulations is around Rs 7.8735. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Unjha Formulations?
Ans: Unjha Formulations has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Unjha Formulations?
Ans: The ROE of Unjha Formulations is 13.8844% and ROCE of Unjha Formulations is 18.1127%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Unjha Formulations a good buy for the long term?
Ans: The Unjha Formulations long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Unjha Formulations undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Unjha Formulations appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Unjha Formulations’s financials?
Ans: You can review Unjha Formulations’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Unjha Formulations
X